Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The illustration shows a portion of the receptor pGC-A, known as the extracellular domain, which protrudes from cell surfaces in the cardiovascular system. Small molecules bind with the receptor and exert subtle control over blood pressure. The new research offers the first sneak peek at the full-length receptor, a vital step in the development of new drugs to treat hypertension and other afflictions.

News | Hypertension

New Study Explores Cell Receptor Crucial for Cardiovascular Health

August 8, 2022 — Cardiovascular diseases remain a leading cause of death around the world. A primary contributor to ...

August 08, 2022

For people with coronary heart disease, beta-blockers can improve survival and quality of life, while aspirin and other antiplatelet medications can reduce the risk of a heart attack.

News | Heart Failure

Two Heart Medications Tied to Greater Heart-attack Risk During Very Hot Weather

August 5, 2022 — For people with coronary heart disease, beta-blockers can improve survival and quality of life, while ...

August 05, 2022

Frank Van Hyfte, VP of Europe, the Middle East and Africa

News | Cardiovascular Business

Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline

August 5, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

August 05, 2022

Providers’ differential decision-making must be addressed to equalize chance of survival for heart failure patients, researchers say

News | Ventricular Assist Devices (VAD)

When Heart-assisting Implants Could Save a Life, Black, Female Patients Don’t Get Them as Often

August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...

August 05, 2022

The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will be presented at TCT 2022. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.

News | TCT

CRF Announces TCT 2022 Late-breaking Clinical Science

August 4, 2022 — The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will ...

August 04, 2022

The Global Defibrillator Market size was valued at $11.30 billion in 2021 and is predicted to reach $21.09 billion by 2030

News | Defibrillator Monitors

Defibrillator Market Size Projected to Reach $21B by 2030

August 3, 2022 — A defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances ...

August 03, 2022

News | TCT

Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)

August 2, 2022 — Two significant awards will be presented at TCT 2022, to be held in Boston, Sept. 16-19, 2022.

Caree ...

August 02, 2022

About one percent of the world population is born with a congenital heart defect, which affects about 40,000 U.S. births each year, but how these particular birth defects come about is largely unknown.

News | Congenital Heart

New Study Provides Insight for How Congenital Heart Defects Manifest

August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about ...

August 02, 2022

A study from the University of Warwick has found that school-based defibrillators (AEDs) that are accessible outside of school hours could be effective in treating over two thirds of Out of Hospital Cardiac Arrests (OHCAs) within five minutes

News | Defibrillator Monitors

Accessible Defibrillators in Schools Could Treat Two-thirds of Out of Hospital Cardiac Arrests

August 1, 2022 — A study from the University of Warwick has found that school-based defibrillators (AEDs) that are ...

August 01, 2022

More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health, especially among people of color, putting both parents-to-be and their babies at risk, according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in July

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

August 01, 2022

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology

News | Mobile C-Arms

Siemens Healthineers Announces FDA Clearance of ARTIS Icono Ceiling Angiography System

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

July 29, 2022

RADIANCE II US FDA IDE pivotal trial evaluating the Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in daytime ambulatory systolic blood pressure between treatment and a sham procedure measured at two months

News | Hypertension

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension

July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings ...

July 29, 2022

a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes

News | Embolization devices

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

July 28, 2022

News | Sudden Cardiac Arrest

Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

July 28, 2022

Human Chest Cavity illustration: Right lung, left lung, heart. Copyright American Heart Association

News | Coronavirus (COVID-19)

Coronavirus Spike Protein Activated Natural Immune Response, Damaged Heart Muscle Cells

July 27, 2022 — Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus ...

July 27, 2022